[1]Shah SS,Satin AM,Mullen JR,et al.Impact of recent guideline changes on aspirin prescribing after knee arthroplasty[J].J Orthop Surg Res,2016,11 (1):1-9.
[2]Pamilo KJ,Torkki P,Peltola M,et al.Fast-tracking for total knee replacement reduces use of institutional care without compromising quality[J].Acta Orthop,2017,89(2):184-189.
[3]Warren JA,Sundaram K,Anis HK,et al.Have venous thromboembolism rates decreased in total hip and knee arthroplasty?[J].J Arthroplasty,2020,35(1):259-264.
[4]Shahi A,Bradbury TL,Guild GN,et al.What arethe incidence and risk factors of in-hospital mortality after venous thromboembolism events in total hip and knee arthroplasty patients?[J].Arthroplast Today,2018,4(3):343-347.
[5]Wakabayashi H,Hasegawa M,Kato S,et al.Clinical analysis of preoperative deep vein thrombosis risk factors in patients undergoing primary total knee arthroplasty[J].Ann Rheum Dis,2016,75(2):965.
[6]White RH.The epidemiology of venous thromboembolism[J].Circulation,2003,107 (23):14-18.
[7]Montagnana M,Favaloro EJ,Franchini MA,et al.The role of ethnicity,age and gender in venous thromboembolism[J].J Thromb Thrombolysis,2010,29(4):489-496.
[8]曾敬,赵洪普,杨展翔,等.全膝关节置换术后静脉血栓栓塞症危险因素的Meta分析[J].中华关节外科杂志(电子版),2019,13(1):78-85.
[9]Mori N,Kimura S,Onodera T,et al.Use of a pneumatic tourniquet in total knee arthroplasty increases the risk of distal deep vein thrombosis:a prospective,randomized study[J].Knee,2016,23(5):887-889.
[10]Wauke K,Nagashima M,Kato N,et al.Comparative study between thromboembolism and total knee arthroplasty with or without tourniquet in rheumatoid arthritis patients[J].Arch Orthop Trauma Surg,2002,122(8):442-446.
[11]Jiang FZ,Zhong HM,Hong YC,et al.Use of a tourniquet in total knee arthroplasty:a systematic review and meta-analysis of randomized controlled trials[J].J Orthop Sci,2015,20(1):110-123.
[12]Caprini JA.Individual risk assessment is the best strategy for thromboembolic prophylaxis[J].Dis Mon,2010,56(10):552-559.
[13]Imai N,Ito T,Suda K,et al.Manual calf massage and passive ankle motion reduce the incidence of deep vein thromboembolism after total hip arthroplasty[J].J Orthop Sci,2017,22(4):726-730.
[14]Epstein NE.Efficacy of pneumatic compression stocking prophylaxis in the prevention of deep venous thrombosis and pulmonary embolism following 139 lumbar laminectomies with instrumented fusions[J].J Spinal Disord Tech,2006,19(1):28-31.
[15]Fuji T,Fujita S,Kimura T,et al.Clinical benefit of graduated compression stockings for prevention of venous thromboembolism after total knee arthroplasty:post hoc analysis of a phase 3 clinical study of edoxaban[J].Thromb J,2016,14(1):1-5.
[16]苗壮,刘培来,卢群山,等.一种骨科术后下肢静脉泵运行模式的研究[J].实用骨科杂志,2020,26(9):847-850.
[17]Pour AE,Keshavarzi NR,Purtill JJ,et al.Is venous foot pump effective in prevention of thromboembolic disease after joint arthroplasty:a meta-analysis[J].J Arthroplasty,2013,28(3):410-417.
[18]Williams KJ,Moore HM,Davies AH.Haemodynamic changes with the use of neuromuscular electrical stimulation compared to intermittent pneumatic compression[J].Phlebol,2015,30(5):365-372.
[19]中华医学会骨科学分会.中国骨科大手术静脉血栓栓塞症预防指南[J].中华骨科杂志,2016,36(2):65-69.
[20]Anderson DR,Dunbar M,Murnaghan J,et al.Aspirin or rivaroxaban for VTE prophylaxis after hip or knee arthroplasty[J].N Engl J Med,2018,378(8):699-707.
[21]Mihaljevic Z,Dimnjakovic D,Tripkovic B,et al.Influence of fondaparinux versus nadroparin calcium thromboprophylaxison clinical parameters following total knee arthroplasty[J].Acta Clin Croat,2016,55(3):414-421.
[22]曹时亮,任毅,冯宾.阿司匹林:关节置换术后抗凝新观念[J].协和医学杂志,2019,10(6):639-646.
[23]Hood BR,Cowen ME,Zheng HT,et al.Association of aspirin with prevention of venousthromboembolism in patients after total knee arthroplasty compared with other anticoagulants:a noninferiority analysis[J].JAMA Surg,2019,154(1):65-72.
[24]Huang HF,Li SS,Yang XT,et al.Rivaroxaban versus enoxaparin forthe prevention of venous thromboembolism after total knee arthroplasty:Ameta-analysis[J].Medicine (Baltimore),2018,97(48):e13465.
[25]Li H,Xu Y,Fu Q,et al.Effects of multiple agents on epithelial differentiation of rabbit adipose-derived stem cells in 3D culture[J].Tissue Eng Part A,2012,18(17/18):1760-1770.
[26]Ning GZ,Kan SL,Chen LX,et al.Rivaroxaban for thromboprophylaxis after total hip or knee arthroplasty:a meta-analysis with trial sequential analysis of randomized controlled trials[J].Sci Rep,2016(6):23726.
[27]Lassen MR,Raskob GE,Gallus A,et al.Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2):a randomised double-blind trial[J].Lancet,2010,375(9717):807-815.
[28]King DA,Pow RE,Dickison DM,et al.Apixaban versus enoxaparin in theprevention of venous thromboembolism following total knee arthroplasty:asingle-centre,single-surgeon,retrospective analysis[J].Intern Med J,2016,46(9):1030-1037.
[29]Friedman RJ,Dahl OE,Rosencher N,et al.Dabigatran versus enoxaparin for prevention of venous thromboembolism after hip or knee arthroplasty:a pooled analysis of three trials[J].Thromb Res,2010,126(3):175-182.